Kiniksa Pharmaceuticals, Ltd.·4

Jul 3, 4:15 PM ET

Cole G Bradley 4

4 · Kiniksa Pharmaceuticals, Ltd. · Filed Jul 3, 2023

Insider Transaction Report

Form 4
Period: 2023-06-29
Transactions
  • Exercise/Conversion

    Restricted Share Units

    2023-06-295,0000 total
    Class A Common Shares (5,000 underlying)
  • Exercise/Conversion

    Class A Common Share

    2023-06-29+5,0005,000 total
Footnotes (2)
  • [F1]Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
  • [F2]The RSUs vested in a single installment on June 29, 2023; there was no expiration date for the RSUs.

Documents

1 file
  • 4
    form4-07032023_040703.xmlPrimary